Bank Of America Corp Geron Corp Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Geron Corp stock. As of the latest transaction made, Bank Of America Corp holds 2,278,262 shares of GERN stock, worth $9.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,278,262

Previous 963,293 136.51%

Holding current value

$9.73 Million

Previous $3.18 Million 203.93%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $4.08 Million - $6.69 Million	1,314,969 Added 136.51%	2,278,262 $9.66 Million
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $728,869 - $1.43 Million	416,497 Added 76.17%	963,293 $3.18 Million
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $441,580 - $586,236	-253,782 Reduced 31.7%	546,796 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $2.99 Million - $5.59 Million	-1,515,615 Reduced 65.44%	800,578 $2.57 Million
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $1.57 Million - $2.49 Million	731,988 Added 46.21%	2,316,193 $5.03 Million
Q4 2022 Feb 10, 2023	BUY	$2.03 - $2.42 $2.16 Million - $2.58 Million	1,065,620 Added 205.49%	1,584,205 $3.83 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $218,828 - $385,242	131,035 Added 33.81%	518,585 $1.21 Million
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.65 $725,938 - $1.01 Million	-610,032 Reduced 61.15%	387,550 $600,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $221,113 - $357,355	-223,347 Reduced 18.29%	997,582 $1.36 Million
Q4 2021 Feb 08, 2022	BUY	$1.22 - $1.72 $1.41 Million - $1.99 Million	1,159,597 Added 1890.69%	1,220,929 $1.49 Million
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $36,686 - $45,858	-30,572 Reduced 33.27%	61,332 $84,000
Q2 2021 Sep 13, 2021	BUY	$1.25 - $1.83 $114,880 - $168,184	91,904 New	91,904 $129,000

Others Institutions Holding GERN

# of Institutions

263

Shares Held

449M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.61B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Geron Corp Transaction History